PLEASANTON, Calif. – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the American Urological Association’s 2015 Annual Meeting from two studies of the company’s novel UroLift® System for patients with Benign Prostatic Hyperplasia (BPH). 
“These results confirm the long-term benefits of the UroLift System and show that it is a compelling alternative to the procedure that has been the standard of care for decades,” said Dave Amerson,  … Continue reading NeoTract, Inc. Announces Excellent Data From Two Studies of the Minimally Invasive UroLift System Treatment for Enlarged Prostate